JAK inhibitors AG-490 and WHI-P154 decrease IFN-γ-induced iNOS expression and NO production in macrophages

Mediators of Inflammation

Volumn 2006, Issue , 2006, Pages

  Sareila, Outi ^a   Korhonen, Riku ^a   Kärpänniemi, Outi ^a   Nieminen, Riina ^a   Kankaanranta, Hannu ^a   Moilanen, Eeva ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMO 4 HYDROXYANILINO) 6,7 DIMETHOXYQUINAZOLINE; DACTINOMYCIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NITRIC OXIDE; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; WHI P 154; ENZYME INHIBITOR; GAMMA INTERFERON ACTIVATION FACTOR; INTERFERON STIMULATED GENE FACTOR 3; JANUS KINASE 1; NITRITE; QUINAZOLINE DERIVATIVE; TYRPHOSTIN; TYRPHOSTIN AG-490;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL STIMULATION; CONCENTRATION RESPONSE; DRUG EFFECT; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL NUCLEUS; DRUG ANTAGONISM; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MURINAE;

ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; ENZYME INHIBITORS; INTERFERON TYPE II; INTERFERON-STIMULATED GENE FACTOR 3; JANUS KINASE 1; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; POLYMERASE CHAIN REACTION; QUINAZOLINES; TYRPHOSTINS;

EID: 33645501147     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI/2006/16161     Document Type: Article

References (24)

1. Blanchette J, Jaramillo M, Olivier M. Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation. Immunology. 2003;108(4):513-522.
2. Gao J, Morrison DC, Parmely TJ, Russell SW, Murphy WJ. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. The Journal of Biological Chemistry. 1997;272(2):1226-1230.
3. Gatto L, Berlato C, Poli V, et al. Analysis of SOCS-3 promoter responses to interferon gamma. The Journal of Biological Chemistry. 2004;279(14):13746- 13754.
4. Geller DA, Billiar TR. Molecular biology of nitric oxide synthases. Cancer and Metastasis Reviews. 1998;17(1):7-23.
5. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry. 1982;126(1):131-138.
6. Ivashkiv LB, Hu X. Signaling by STATs. Arthritis Research & Therapy. 2004;6(4):159-168.
7. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285(1-2):1-24.
8. Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. European Journal of Pharmacology. 2004;500(1-3):255-266.
9. Korhonen R, Lahti A, Hamalainen M, Kankaanranta H, Moilanen E. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Molecular Pharmacology. 2002;62(3):698-704.
10. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Current Drug Targets. Inflammation and Allergy. 2005;4(4):471-479.
11. Lahti A, Jalonen U, Kankaanranta H, Moilanen E. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Molecular Pharmacology. 2003;64(2):308-315.
12. Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications. Annual Review of Immunology. 1998;16:293-322.
13. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annual Review of Immunology. 1997;15:323-350.
14. Martinez-Lostao L, Briones J, Forne I, et al. Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma. 2005;46(3):435-442.
15. Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996;84(3):431-442.
16. Moilanen E, Whittle BJ, Moncada S. Nitric oxide as a factor of inflammation. In: Gallin JI, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:787-801.
17. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews. Immunology. 2005;5(5):375-386.
18. Sanders SP. Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic? American Journal of Respiratory Cell and Molecular Biology. 1999;21(2):147-149.
19. Song HY, Jeon ES, Jung JS, Kim JH. Oncostatin M induces proliferation of human adipose tissue-derived mesenchymal stem cells. The International Journal of Biochemistry & Cell Biology. 2005;37(11):2357-2365.
20. Sudbeck EA, Liu XP, Narla RK, et al. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clinical Cancer Research. 1999;5(6):1569-1582.
21. Tibbles HE, Vassilev A, Wendorf H, et al. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. The Journal of Biological Chemistry. 2001;276(21):17815-17822.
22. Vallance P, Leiper J. Blocking NO synthesis: how, where and why? Nature Reviews. Drug Discovery. 2002;1(12):939-950.
23. van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology. 2001;103(3):255-261.
24. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. The Journal of Biological Chemistry. 1994;269(7):4705-4708.